|This module is part of the 2021 Nebraska Medicine Primary Care Education On-Demand Series.|
Kidney Transplantation: Overview & Updates
Clifford Miles, MD, FAST
Associate professor, Division of Nephrology, Department of Internal Medicine, UNMC; medical director, Kidney and Pancreas Transplantation, Nebraska Medicine
Upon completion of this on-demand module, participants should be better able to:
- Review data regarding the prevalence of end-stage kidney disease and the modalities of treatment.
- Discuss the impact of a limited supply of donated kidneys, including transplant candidacy and the waiting list.
- Describe ways that patients, providers and transplant teams can address the organ shortage, with emphasis on living donation.
- Briefly describe clinical trials available to Nebraska Medicine kidney transplant patients.
Method of Participation
- Review the entire activity
- Complete the post-test and evaluation
- This activity will take approximately 1 hour to complete
Term of Approval
Release Date: May 10, 2021
Expiration Date: Dec. 15, 2022
Continuing Education Credits
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Nebraska Medicine. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Nebraska Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.0 Contact Hour Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Faculty and Planning Committee Disclosures
Disclosure Declaration (PDF)
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners and others in control of content prior to assuming their roles:
- Clifford Miles, MD, FAST
Advisory Board: CareDX, Veloxis Pharmaceuticals
Research Grant Support: Talaris Pharmaceuticals
The below planning committee members have nothing to disclose:
- Michelle Grady, MHA
- Jacqueline Siebels, BSN, RN, NPD-BC
- Whitney Van Arsdall